Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jun;4(3):197-202.
doi: 10.3978/j.issn.2304-3881.2014.11.08.

Detectability and clinical significance of serum hepatitis B virus ribonucleic acid

Yi-Wen Huang  1 , Kazuaki Chayama  1 , Jia-Horng Kao  1 , Sien-Sing Yang  1
Affiliations
Review

Detectability and clinical significance of serum hepatitis B virus ribonucleic acid

Yi-Wen Huang et al. Hepatobiliary Surg Nutr. 2015 Jun.

Abstract

Serum hepatitis B virus (HBV) RNA is detected during treatment with nucleoside analogue as a consequence of interrupted reverse transcription (RT) and unaffected replicative intermediates. The presence of serum HBV RNA in chronic HBV patients is confirmed by using ribonuclease digestion. Serum HBV RNA is differentially inhibited by interferon, but not by nucleoside analogue. The inhibitory effect of interferon on HBV RNA replicative intermediates may potentiate the suppression of HBV replication. Clinical significance of serum HBV RNA includes: (I) reflect the antiviral potency of nucleoside analogue; (II) predictor of early emergence of viral mutation during lamivudine therapy; (III) independently predict initial virologic response or earlier HBV suppression during nucleoside analogue therapy; (IV) predict HBV reactivation after discontinuation of nucleoside analogue. Thus, serum HBV RNA might be useful to optimize treatment efficacy in patients with chronic HBV, including shifting of oral antivirals or conversion to immunomodulatory agent i.e., interferon. Furthermore, serum HBV RNA levels correlate better with serum quantitative HBsAg (qHBsAg) than with serum HBV DNA levels. The predictive role of serum HBV RNA in long-term treatment effects of nucleoside analogue needs further study.

Keywords: Nucleoside analogue; interferon; replicative intermediates.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Lee WM. Hepatitis B virus infection. N Engl J Med 1997;337:1733-45. - PubMed
    1. Kao JH, Chen DS. Overview of hepatitis B and C viruses. In: Goedert JJ, editor. Infectious Causes of Cancer: Targets for Intervention. Totowa: Humana Press, 2000:313-30.
    1. McQuillan GM, Townsend TR, Fields HA, et al. Seroepidemiology of hepatitis B virus infection in the United States. 1976 to 1980. Am J Med 1989;87:5S-10S. - PubMed
    1. Chen DS. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science 1993;262:369-70. - PubMed
    1. Chen DS. Fighting against viral hepatitis: lessons from Taiwan. Hepatology 2011;54:381-92. - PubMed